Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Madji Hounoum

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Neurology|January 30, 2016
Metabolomics in amyotrophic lateral sclerosis: how far can it take us?H Blasco, F Patin, B Madji Hounoum, et al.
European Journal of Neurology|June 23, 2015
Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosisF Patin, P Corcia, B Madji Hounoum, et al.
European Journal of Neurology|October 29, 2015
Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progressionH Blasco, L Nadal-Desbarats, P-F Pradat, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Neurology|January 30, 2016
Metabolomics in amyotrophic lateral sclerosis: how far can it take us?H Blasco, F Patin, B Madji Hounoum, et al.
European Journal of Neurology|June 23, 2015
Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosisF Patin, P Corcia, B Madji Hounoum, et al.
European Journal of Neurology|October 29, 2015
Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progressionH Blasco, L Nadal-Desbarats, P-F Pradat, et al.
Pageof 1